Machine Learning for Cancer Immunotherapies Based on Epitope Recognition by T Cell Receptors
In the last years, immunotherapies have shown tremendous success as treatments for multiple types of cancer. However, there are still many obstacles to overcome in order to increase response rates and identify effective therapies for every individual patient. Since there are many possibilities to bo...
Main Authors: | Anja Mösch, Silke Raffegerst, Manon Weis, Dolores J. Schendel, Dmitrij Frishman |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fgene.2019.01141/full |
Similar Items
-
An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2017-11-01) -
Corrigendum: An Analysis of Natural T Cell Responses to Predicted Tumor Neoepitopes
by: Anne-Mette Bjerregaard, et al.
Published: (2018-05-01) -
Expitope 2.0: a tool to assess immunotherapeutic antigens for their potential cross-reactivity against naturally expressed proteins in human tissues
by: Victor Jaravine, et al.
Published: (2017-12-01) -
Predicting T cell recognition of MHC class I restricted neoepitopes
by: Zeynep Koşaloğlu-Yalçın, et al.
Published: (2018-11-01) -
ProTECT—Prediction of T-Cell Epitopes for Cancer Therapy
by: Arjun A. Rao, et al.
Published: (2020-11-01)